ofloxacin has been researched along with epiglucan in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dúhová, V; Kogan, G; Miadoková, E; Moránová, Z; Nadová, S; Rauko, P; Vlcková, V; Závodná, K | 1 |
| Braem, A; Cammue, BP; De Brucker, K; De Cremer, K; Michiels, J; Tan, Y; Thevissen, K; Verstraeten, N; Vints, K; Vleugels, J | 1 |
2 other study(ies) available for ofloxacin and epiglucan
| Article | Year |
|---|---|
Natural microbial polysaccharide sulphoethyl glucan as antigenotoxic and cancer preventing agent.
Topics: Animals; Anti-Bacterial Agents; Anticarcinogenic Agents; Antimutagenic Agents; beta-Glucans; Cell Division; Cell Wall; Chlamydomonas reinhardtii; DNA Damage; Methyl Methanesulfonate; Mutagens; Ofloxacin; Proteoglycans; Saccharomyces cerevisiae; Teniposide; Vicia faba; Vicia sativa | 2006 |
Fungal β-1,3-glucan increases ofloxacin tolerance of Escherichia coli in a polymicrobial E. coli/Candida albicans biofilm.
Topics: Antifungal Agents; beta-Glucans; Biofilms; Candida albicans; Drug Resistance, Fungal; Escherichia coli; Ofloxacin | 2015 |